These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 39231085)

  • 1. A Cosmetic Regimen Formulated to Address the Multi-Modal Pathogenesis of Rosacea Demonstrates Efficacy for Treating Facial Redness and Skin's Appearance.
    Farris PK; Gerstein FH; Baldwin HE; Draelos ZD
    J Drugs Dermatol; 2024 Sep; 23(9):757-763. PubMed ID: 39231085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Skin compatibility and efficacy of a cosmetic skin care regimen with licochalcone A and 4-t-butylcyclohexanol in patients with rosacea subtype I.
    Schoelermann AM; Weber TM; Arrowitz C; Rizer RL; Qian K; Babcock M
    J Eur Acad Dermatol Venereol; 2016 Feb; 30 Suppl 1():21-7. PubMed ID: 26805419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Open-label study assessing the efficacy and tolerability of topical skin care and sun protection alone and in combination with intense pulsed light therapy.
    Deaver Peterson J; Katz TM
    J Cosmet Dermatol; 2019 Dec; 18(6):1758-1764. PubMed ID: 31017734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel moisturizer with high sun protection factor improves cutaneous barrier function and the visible appearance of rosacea-prone skin.
    Baldwin H; Santoro F; Lachmann N; Teissedre S
    J Cosmet Dermatol; 2019 Dec; 18(6):1686-1692. PubMed ID: 30803131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Skin tolerance, efficacy, and quality of life of patients with red facial skin using a skin care regimen containing Licochalcone A.
    Weber TM; Ceilley RI; Buerger A; Kolbe L; Trookman NS; Rizer RL; Schoelermann A
    J Cosmet Dermatol; 2006 Sep; 5(3):227-32. PubMed ID: 17177744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Clinical Efficacy of Lapachol in Facial Redness Reduction.
    Draelos ZD
    J Cosmet Dermatol; 2024 Nov; 23(11):3662-3666. PubMed ID: 39328086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The appearance of facial foundation cosmetics applied after metronidazole gel 1%.
    Draelos ZD; Colón LE; Preston N; Johnson LA; Gottschalk RW
    Cutis; 2011 May; 87(5):251-9. PubMed ID: 21699130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pivotal Trial of the Efficacy and Safety of Oxymetazoline Cream 1.0% for the Treatment of Persistent Facial Erythema Associated With Rosacea: Findings from the Second REVEAL Trial.
    Baumann L; Goldberg DJ; Stein Gold L; Tanghetti EA; Lain E; Kaufman J; Weng E; Berk DR; Ahluwalia G
    J Drugs Dermatol; 2018 Mar; 17(3):290-298. PubMed ID: 29537447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural Skin Care Products as Adjunctive to Prescription Therapy in Moderate to Severe Rosacea.
    Draelos ZD; Gunt H; Levy SB
    J Drugs Dermatol; 2019 Feb; 18(2):141-146. PubMed ID: 30794364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Novel Protection and Repair Skincare Regimen Shows Efficacy for Improving Environmental Skin Aging.
    Farris PK; Draelos ZD; Tanaka Y; Bucay V; Biotech AAM; Ribeiro N; Parker R
    J Drugs Dermatol; 2024 Oct; 23(10):866-872. PubMed ID: 39361703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrative skincare trial of intense pulsed light followed by the phyto-corrective mask, phyto-corrective gel, and resveratrol BE for decreasing post-procedure downtime and improving procedure outcomes in patients with rosacea.
    Barbarino SC; Bucay VW; Cohen JL; Gold MH
    J Cosmet Dermatol; 2022 Sep; 21(9):3759-3767. PubMed ID: 35765796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brightening and Improvement of Facial Skin Quality in Healthy Female Subjects With Moderate Hyperpigmentation or Dark Spots and Moderate Facial Aging.
    Serra M; Bohnert K; Narda M; Granger C; Sadick N
    J Drugs Dermatol; 2018 Dec; 17(12):1310-1315. PubMed ID: 30586263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Open-Label assessment of the efficacy and tolerability of a skin care regimen for treating subjects with visible and physical symptoms of sensitive skin.
    Turner EO
    J Cosmet Dermatol; 2022 Sep; 21(9):3876-3887. PubMed ID: 35639491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An open-label, single-site study to evaluate the tolerability, safety, and efficacy of using a novel facial moisturizer for preparation and accelerated healing pre and post a single full-face radiofrequency microneedling treatment.
    Zahr AS; Kononov T; Sensing W; Biron JA; Gold MH
    J Cosmet Dermatol; 2019 Feb; 18(1):94-106. PubMed ID: 30456804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Effect of an Anti-Inflammatory Botanical Cleanser/Night Mask Combination on Facial Redness Reduction.
    Draelos ZD; Donald A
    J Drugs Dermatol; 2018 Jun; 17(6):671-676. PubMed ID: 29879255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of a novel rosacea treatment system: an investigator-blind, randomized, parallel-group study.
    Leyden JJ
    J Drugs Dermatol; 2011 Oct; 10(10):1179-85. PubMed ID: 21968669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brimonidine gel 0.33% rapidly improves patient-reported outcomes by controlling facial erythema of rosacea: a randomized, double-blind, vehicle-controlled study.
    Layton AM; Schaller M; Homey B; Hofmann MA; Bewley AP; Lehmann P; Nohlgård C; Sarwer DB; Kerrouche N; Ma YM
    J Eur Acad Dermatol Venereol; 2015 Dec; 29(12):2405-10. PubMed ID: 26416154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pivotal Trial of the Efficacy and Safety of Oxymetazoline Cream 1.0% for the Treatment of Persistent Facial Erythema Associated With Rosacea: Findings from the First REVEAL Trial.
    Kircik LH; DuBois J; Draelos ZD; Werschler P; Grande K; Cook-Bolden FE; Weng E; Berk DR; Ahluwalia G
    J Drugs Dermatol; 2018 Jan; 17(1):97-105. PubMed ID: 29320594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An Open-Label, Intra-Individual Study to Evaluate a Regimen of Three Cosmetic Products Combined with Medical Treatment of Rosacea: Cutaneous Tolerability and Effect on Hydration.
    Santoro F; Lachmann N
    Dermatol Ther (Heidelb); 2019 Dec; 9(4):775-784. PubMed ID: 31625112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of oxymetazoline cream 1.0% for treatment of persistent facial erythema associated with rosacea: Findings from the 52-week open label REVEAL trial.
    Draelos ZD; Gold MH; Weiss RA; Baumann L; Grekin SK; Robinson DM; Kempers SE; Alvandi N; Weng E; Berk DR; Ahluwalia G
    J Am Acad Dermatol; 2018 Jun; 78(6):1156-1163. PubMed ID: 29409914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.